Skip to main content

Table 4 Institutional factors associated with the number of patients enrolled per year (multivariate linear mixed model)

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

  All institutions (N = 4,946 patients)
  β p-value CI 95%
Year 11.91 <10-4 [5.90; 17.93]
Interactions    
Year*public 2.08 0.93 [-42.92; 47.08]
Year*hematologist or oncologist 6.12 0.02 [0.98; 11.27]
Year*research -2.59 0.13 [-5.94; 0.75]
Year*bone aspiration -8.78 <10-4 [-12.89; -4.66]
Year*Europe 0.00 (ref)   
Year*SE Asia 3.04 0.34 [-3.24; 9.33]
Year*East Africa -0.59 0.78 [-4.86;3.67]
Year*West Africa -11.49 <10-4 [-15.53; -7.45]
Year*Pacific/America -14.66 <10-4 [-19.54; -9.77]
  1. Results in bold are statistically significant at the 5% level.
\